Xenetic Biosciences Inc (XBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,884 | 4,122 | 4,780 | 5,164 | 6,166 |
| TOTAL | $8,050 | $5,068 | $5,354 | $5,477 | $6,588 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 314 | 0 | 0 | 314 | 314 |
| TOTAL | $314 | $N/A | $N/A | $314 | $314 |
| Total Assets | $8,364 | $5,068 | $5,354 | $5,791 | $6,901 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 258 | 578 | 347 | 240 | 284 |
| Accrued Expenses | 710 | 534 | 557 | 428 | 611 |
| TOTAL | $968 | $1,112 | $903 | $668 | $894 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $968 | $1,112 | $903 | $668 | $894 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,291 | 2,291 | 1,542 | 1,542 | 1,542 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -199,875 | -199,296 | -198,786 | -198,098 | -197,195 |
| Other shareholders' equity | -28 | -27 | -27 | -27 | -27 |
| TOTAL | $7,396 | $3,956 | $4,450 | $5,123 | $6,007 |
| Total Liabilities And Equity | $8,364 | $5,068 | $5,354 | $5,791 | $6,902 |